A02-K03 菅波 孝祥(名古屋大学 環境医学研究所)

A02-K03 菅波 孝祥(名古屋大学 環境医学研究所)

  1. Y. Kanamori, M. Tanaka, M. Itoh, K. Ochi, A. Ito, I. Hidaka, I. Sakaida, Y. Ogawa, T. Suganami: “Iron-rich Kupffer Cells Exhibit Phenotypic Changes during the Development of Liver Fibrosis in NASH” iScience 24, 102032 (2021) DOI: https://doi.org/10.1016/j.isci.2020.102032
  2. M. Tanaka, M. Saka-Tanaka, K. Ochi, K. Fujieda, Y. Sugiura, T. Miyamoto, H. Kohda, A. Ito, T. Miyazawa, A. Matsumoto, S. Aoe, Y. Miyamoto, N. Tsuboi, S. Maruyama, M. Suematsu, S. Yamasaki, Y. Ogawa, T. Suganami. “C-type Lectin Mincle Mediates Cell Death–triggered Sustained Inflammation in Acute Kidney Injury.” J. Exp. Med. 217, e20192230 (2020) DOI: https://doi.org/10.1084/jem.20192230
  3. K. Kurita, H. Ohta, I. Shirakawa, M. Tanaka, Y. Kitaura, Y. Iwasaki, T. Matsuzaka, H. Shimano, S. Aoe, H. Arima, Y. Ogawa, A. Ito, T. Suganami: “Macrophages Rely on Extracellular Serine to Suppress Aberrant Cytokine Production” Sci. Rep. 11, 11137 (2021) DOI: https://doi.org/10.1038/s41598-021-90086-w
  4. N. Yoshioka, M. Tanaka, K. Ochi, A. Watanabe, K. Ono, M. Sawada, T. Ogi, M. Itoh, A. Ito, Y. Shiraki, A. Enomoto, M. Ishigami, M. Fujishiro, Y. Ogawa, T. Suganami: “The Sodium-glucose Cotransporter-2 Inhibitor Tofogliflozin Prevents the Progression of Nonalcoholic Steatohepatitis–associated Liver Tumors in a Novel Murine Model” Biomed. Pharmacother. 140, 111738 (2021) DOI: https://doi.org/10.1016/j.biopha.2021.111738
  5. A. Kobayashi, A. Ito, I. Shirakawa, A. Tamura, S. Tomono, H. Shindou, P. Niklas Hedde, M. Tanaka, N. Tsuboi, T. Ishimoto, S. Akashi-Takamura, S. Maruyama, T. Suganami: “Dietary Supplementation with Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity” Front. Immunol. 12, 650856 (2021) DOI: https://doi.org/10.3389/fimmu.2021.650856
  6. T. Inoue, B. Fu, M. Nishio, M. Tanaka, H. Kato, M. Tanaka, M. Itoh, H. Yamakage, K. Ochi, A. Ito, Y. Shiraki, S. Saito, M. Ihara, H. Nishimura, A. Kawamoto, S. Inoue, K. Saeki, A. Enomoto, T. Suganami, N. Satoh-Asahara: “Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis” Nutrients 15, 350 (2023) DOI: https://doi.org/10.3390/nu15020350
  7. M. Itoh, A. Tamura, S. Kanai, M. Tanaka, Y. Kanamori, I. Shirakawa, A. Ito, Y. Oka, I. Hidaka, T. Takami, Y. Honda, M. Maeda, Y. Saito, Y. Murata, T. Matozaki, A. Nakajima, Y. Kataoka, T. Ogi, Y. Ogawa, T. Suganami. “Lysosomal Cholesterol Overload Triggers Macrophage Phenotypic Changes and Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis.” J. Exp. Med. 220, e20220681 (2023) DOI: https://doi.org/10.1084/jem.20220681
PAGE TOP